NEA Management Company’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,252,994
| Closed | -$240M | – | 28 |
|
|
2025
Q3 | $240M | Sell |
2,252,994
-10,144
| -0.4% | -$1.06M | 13.19% | 3 |
|
|
2025
Q2 | $214M | Sell |
2,263,138
-425,427
| -16% | -$31.5M | 16.11% | 2 |
|
|
2025
Q1 | $171M | Sell |
2,688,565
-2,896,188
| -52% | -$173M | 13.15% | 2 |
|
|
2024
Q4 | $259M | Hold |
5,584,753
| – | – | 14.64% | 2 |
|
|
2024
Q3 | $161M | Hold |
5,584,753
| – | – | 8.75% | 3 |
|
|
2024
Q2 | $80.8M | Buy |
5,584,753
+476,190
| +9% | +$6.95M | 6.08% | 7 |
|
|
2024
Q1 | $89.9M | Hold |
5,108,563
| – | – | 5.58% | 7 |
|
|
2023
Q4 | $111M | Hold |
5,108,563
| – | – | 7.4% | 5 |
|
|
2023
Q3 | $91M | Hold |
5,108,563
| – | – | 7.03% | 4 |
|
|
2023
Q2 | $118M | Sell |
5,108,563
-476,190
| -9% | -$10.2M | 9.01% | 3 |
|
|
2023
Q1 | $112M | Hold |
5,584,753
| – | – | 7.75% | 3 |
|
|
2022
Q4 | $146M | Hold |
5,584,753
| – | – | 8.2% | 3 |
|
|
2022
Q3 | $57.1M | Buy |
5,584,753
+476,190
| +9% | +$4.01M | 2.85% | 12 |
|
|
2022
Q2 | $21.4M | Hold |
5,108,563
| – | – | 1.1% | 23 |
|
|
2022
Q1 | $25.5M | Hold |
5,108,563
| – | – | 0.74% | 22 |
|
|
2021
Q4 | $34.3M | Hold |
5,108,563
| – | – | 0.69% | 22 |
|
|
2021
Q3 | $27.9M | Hold |
5,108,563
| – | – | 0.33% | 29 |
|
|
2021
Q2 | $33.4M | Hold |
5,108,563
| – | – | 0.44% | 33 |
|
|
2021
Q1 | $42.7M | Hold |
5,108,563
| – | – | 0.96% | 26 |
|
|
2020
Q4 | $35.8M | Hold |
5,108,563
| – | – | 0.94% | 25 |
|
|
2020
Q3 | $31.9M | Buy |
5,108,563
+3,888,889
| +319% | +$26.9M | 1.35% | 20 |
|
|
2020
Q2 | $5.71M | Hold |
1,219,674
| – | – | 0.23% | 40 |
|
|
2020
Q1 | $5.03M | Hold |
1,219,674
| – | – | 0.26% | 39 |
|
|
2019
Q4 | $7.01M | Hold |
1,219,674
| – | – | 0.33% | 35 |
|
|
2019
Q3 | $5.57M | Hold |
1,219,674
| – | – | 0.46% | 31 |
|
|
2019
Q2 | $6.22M | Hold |
1,219,674
| – | – | 0.44% | 31 |
|
|
2019
Q1 | $7.93M | Hold |
1,219,674
| – | – | 0.41% | 33 |
|
|
2018
Q4 | $11M | Hold |
1,219,674
| – | – | 0.44% | 31 |
|
|
2018
Q3 | $15.3M | Hold |
1,219,674
| – | – | 0.66% | 29 |
|
|
2018
Q2 | $16.7M | Hold |
1,219,674
| – | – | 0.78% | 24 |
|
|
2018
Q1 | $24.4M | Hold |
1,219,674
| – | – | 1.09% | 23 |
|
|
2017
Q4 | $14.5M | Hold |
1,219,674
| – | – | 0.6% | 25 |
|
|
2017
Q3 | $18.7M | Buy |
1,219,674
+553,008
| +83% | +$7.3M | 0.66% | 22 |
|
|
2017
Q2 | $7.77M | Buy |
+666,666
| New | +$8.83M | 0.28% | 29 |
|
Other funds holding VRNA
NEA Management Company's VRNA Position: Q4 2025 in Review
NEA Management Company sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 2,252,994 shares — an estimated $240M sold.
NEA Management Company first reported a position in VRNA in Q2 2017 and held it in 34 quarters. The position peaked at $259M in Q4 2024. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.
- NEA Management Company reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
- NEA Management Company sold 2,252,994 Verona Pharma shares in Q4 2025, an estimated $240M.
- NEA Management Company first reported a position in Verona Pharma in Q2 2017 and held it in 34 quarters.
- NEA Management Company's Verona Pharma position peaked at $259M in Q4 2024.
- 1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.
Based on NEA Management Company's 13F filing for Q4 2025, filed 17 Feb 2026.